Histone acetylation is the most-studied histone modification in the context of AD as dysregulation of histone acetylation and increases in histone deacetylase (HDAC) activity have been correlated with worse AD pathological outcomes [1,2,3]. Here, HDAC9 is linked to Alzheimer disease.